HIM
AMPH icon

Hillsdale Investment Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Hillsdale Investment Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-39,279
Closed -$1.72M – 579
2024
Q1 		$1.72M Sell
39,279
-57,074
-59% -$2.95M 0.14% 188
2023
Q4 		$5.96M Sell
96,353
-195
-0.2% -$10.2K 0.49% 34
2023
Q3 		$4.44M Sell
96,548
-3,660
-4% -$200K 0.41% 70
2023
Q2 		$5.76M Sell
100,208
-54,830
-35% -$2.43M 0.53% 43
2023
Q1 		$5.81M Sell
155,038
-17,200
-10% -$564K 0.5% 54
2022
Q4 		$4.83M Sell
172,238
-25,500
-13% -$740K 0.41% 77
2022
Q3 		$5.56M Hold
197,738
– – 0.5% 52
2022
Q2 		$6.88M Sell
197,738
-36,600
-16% -$1.31M 0.55% 34
2022
Q1 		$8.41M Buy
+234,338
New +$6.65M 0.54% 32
2019
Q3 		– Sell
-33,800
Closed -$714K – 609
2019
Q2 		$714K Buy
33,800
+6,800
+25% +$142K 0.07% 267
2019
Q1 		$552K Buy
27,000
+4,400
+19% +$98.6K 0.05% 273
2018
Q4 		$450K Buy
+22,600
New +$445K 0.05% 269

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hillsdale Investment Management's AMPH Position: Q2 2024 in Review

Hillsdale Investment Management sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2024, closing a stake of 39,279 shares — an estimated $1.72M sold.

Hillsdale Investment Management first reported a position in AMPH in Q4 2018 and held it in 12 quarters. The position peaked at $8.41M in Q1 2022. 268 funds tracked by Wall St. Rank hold AMPH as of Q2 2024.

  • Hillsdale Investment Management reported no remaining Amphastar Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Hillsdale Investment Management sold 39,279 Amphastar Pharmaceuticals shares in Q2 2024, an estimated $1.72M.
  • Hillsdale Investment Management first reported a position in Amphastar Pharmaceuticals in Q4 2018 and held it in 12 quarters.
  • Hillsdale Investment Management's Amphastar Pharmaceuticals position peaked at $8.41M in Q1 2022.
  • 268 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2024.

Based on Hillsdale Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.